Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.2
69.19%
60%
—
99.61%
80%
—
5 Years
Score6.2
Net Growth69.19%
Net Trend60%
Net Income Consistency—
Rev Growth99.61%
Rev Trend80%
Revenue Consistency—
Adaptive Biotechnologies Corp fundamental performance
Between 2020 and 2025, revenue grew from $ 98M to $ 276M and net income went from -$ 146M to -$ 59M. Revenue increased in 4 of those 5 years; net income in 3.
Adaptive Biotechnologies Corp currently holds a 5-year HDB Score of 6.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 25.25 | — |
1 Year2025-08-12 | $ 12.66 | 99.45% |
5 Years2021-08-12 | $ 32.58 | -22.50% |
All Time2019-06-27 | $ 40.30 | -37.34% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-06-27 |
|---|---|---|---|---|
| Price | $ 25.25 | $ 12.66 | $ 32.58 | $ 40.30 |
| Return | — | 99.45% | -22.50% | -37.34% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 308M | -$ 63M | $ 344M |
| 2025 | $ 276M | -$ 59M | $ 226M |
| 2024 | $ 178M | -$ 159M | $ 222M |
| 2023 | $ 170M | -$ 225M | $ 346M |
| 2022 | $ 185M | -$ 200M | $ 498M |
| 2021 | $ 154M | -$ 207M | $ 353M |
| 2020 | $ 98M | -$ 146M | $ 688M |
| IPO2019 | $ 85M | -$ 68M | $ 576M |
Explore beyond ADPT
You're looking at Adaptive Biotechnologies Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
